AU2882899A - Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex - Google Patents
Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complexInfo
- Publication number
- AU2882899A AU2882899A AU28828/99A AU2882899A AU2882899A AU 2882899 A AU2882899 A AU 2882899A AU 28828/99 A AU28828/99 A AU 28828/99A AU 2882899 A AU2882899 A AU 2882899A AU 2882899 A AU2882899 A AU 2882899A
- Authority
- AU
- Australia
- Prior art keywords
- sarcolemmal
- dystrophic
- degeneration
- restoration
- stable protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4707—Muscular dystrophy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7600598P | 1998-02-26 | 1998-02-26 | |
US60076005 | 1998-02-26 | ||
PCT/US1999/004367 WO1999043360A1 (en) | 1998-02-26 | 1999-02-26 | Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2882899A true AU2882899A (en) | 1999-09-15 |
Family
ID=22129324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28828/99A Abandoned AU2882899A (en) | 1998-02-26 | 1999-02-26 | Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2882899A (en) |
WO (1) | WO1999043360A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262035B1 (en) | 1998-10-01 | 2001-07-17 | University Of Iowa Research Foundation | Gene replacement therapy for muscular dystrophy |
WO2005030292A2 (en) | 2003-09-26 | 2005-04-07 | The Trustees Of The University Of Pennsylvania | Methods, compositions and apparatus for delivering heterologous molecules to cells |
US20090054823A1 (en) | 2004-09-30 | 2009-02-26 | The Trustees Of The University Of Pennsylvania | Perfusion circuit and use therein in targeted delivery of macromolecules |
EP3151866B1 (en) | 2014-06-09 | 2023-03-08 | Voyager Therapeutics, Inc. | Chimeric capsids |
CA2966620A1 (en) | 2014-11-05 | 2016-05-12 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
CA3193811A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
WO2016077689A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
WO2016094783A1 (en) | 2014-12-12 | 2016-06-16 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
US11326182B2 (en) | 2016-04-29 | 2022-05-10 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
KR102427379B1 (en) | 2016-05-18 | 2022-08-02 | 보이저 테라퓨틱스, 인크. | Compositions and methods for treating Huntington's disease |
IL302748A (en) | 2016-05-18 | 2023-07-01 | Voyager Therapeutics Inc | modulatory polynucleotides |
US11298041B2 (en) | 2016-08-30 | 2022-04-12 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
SG11201909870SA (en) | 2017-05-05 | 2019-11-28 | Voyager Therapeutics Inc | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
AU2018261003A1 (en) | 2017-05-05 | 2019-11-14 | Voyager Therapeutics, Inc. | Compositions and methods of treating Huntington's Disease |
JOP20190269A1 (en) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
CN111132626B (en) | 2017-07-17 | 2024-01-30 | 沃雅戈治疗公司 | track array guidance system |
JP7221275B2 (en) | 2017-08-03 | 2023-02-13 | ボイジャー セラピューティクス インコーポレイテッド | Compositions and methods for delivering AAV |
EP3687582A4 (en) | 2017-09-29 | 2021-07-14 | Voyager Therapeutics, Inc. | RESCUE OF CENTRAL AND PERIPHERAL NEUROLOGICAL PHENOTYPE OF FRIEDREICH ATAXIA THROUGH INTRAVENOUS ADMINISTRATION |
TWI804518B (en) | 2017-10-16 | 2023-06-11 | 美商航海家醫療公司 | Treatment of amyotrophic lateral sclerosis (als) |
EP3697908A1 (en) | 2017-10-16 | 2020-08-26 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
US20230040544A1 (en) * | 2019-12-16 | 2023-02-09 | Research Institute At Nationwide Children's Hospital | Compositions and methods for restoring and maintaining the dystrophin-associated protein complex (dapc) |
WO2022165313A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5449616A (en) * | 1990-05-23 | 1995-09-12 | University Of Iowa Research Foundation | Nucleic acid encoding dystrophin-associated protein |
US5260209A (en) * | 1990-05-23 | 1993-11-09 | University Of Iowa Research Foundation | Nucleic acids encoding dystrophin-associated proteins |
US5672694A (en) * | 1995-10-24 | 1997-09-30 | University Of Iowa Research Foundation | β-sarcoglycan nucleic acid sequence, and nucleic acid probes |
US5837537A (en) * | 1996-09-25 | 1998-11-17 | Washington University | δ-sarcoglycan nucleic acid sequences |
-
1999
- 1999-02-26 AU AU28828/99A patent/AU2882899A/en not_active Abandoned
- 1999-02-26 WO PCT/US1999/004367 patent/WO1999043360A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999043360A1 (en) | 1999-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2882899A (en) | Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex | |
PL345413A1 (en) | Cosmetic preparation of active substances with high protection factor against free radicals | |
IL135176A0 (en) | Benzothiazole derivatives and pharmaceutical compositions containing the same | |
IL202633A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
IL141456A0 (en) | Rhodanine derivatives and pharmaceutical compositions containing the same | |
IL138899A0 (en) | Amidene derivatives and pharmaceutical compositions containing the same | |
IL135589A0 (en) | Aminothiazole derivatives and pharmaceutical compositions containing the same | |
IL140862A0 (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the same | |
IL149757A0 (en) | Aminothiazole derivatives and pharmaceutical compositions containing the same | |
IL150224A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
HUP0400887A3 (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same | |
IL144977A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
IL150223A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
IL136940A0 (en) | Sulphonamide derivatives and pharmaceutical compositions containing the same | |
IL143920A0 (en) | 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same | |
IL131319A0 (en) | 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same | |
IL138725A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
AU5880498A (en) | New benzolactam derivatives and medicinal compositions containing the same | |
IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
AU5565099A (en) | Pharmaceutical compositions and methods for use | |
HUP0100680A3 (en) | Indole derivatives and medicinal compositions containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |